Competition in International Generic Drug Markets

Étienne Gaudette ^{1, 2}

Shirin Rizzardo ²

Kevin R. Pothier ²

Mina Tadrous ^{3, 4}

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada |

National Prescription Drug Utilization Information System Research Initiative, Patented Medicine Prices Review Board, Government of Canada, Ottawa, Ontario, Canada |

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada |

⁴

Women’s College Hospital, Toronto, Ontario, Canada |

Publication type: Journal Article

Publication date: 2024-10-11

American Medical Association (AMA)

Journal: JAMA Health Forum

scimago Q1

wos Q1

SJR: 1.534

CiteScore: 4.0

Impact factor: 9.5

ISSN: 26890186

DOI: 10.1001/jamahealthforum.2024.3391

Copy DOI

Abstract

This cross-sectional study compares the small molecule generic drug markets of a group of high-income countries with similar pharmaceutical regulatory environments.

Found

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Publication PDF

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

American Medical Association (AMA)

Journal

JAMA Health Forum

scimago Q1

wos Q1

SJR

1.534

CiteScore

4.0

Impact factor

9.5

ISSN

26890186 (Electronic)